These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8560767)

  • 21. Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.
    Dimitrov DS; Golding H; Blumenthal R
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):799-805. PubMed ID: 1742075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The envelope of HIV-1 as a key component to infectivity.
    Buchbinder A
    Prog AIDS Pathol; 1990; 2():1-11. PubMed ID: 2103853
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.
    Cao J; Park IW; Cooper A; Sodroski J
    J Virol; 1996 Mar; 70(3):1340-54. PubMed ID: 8627650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells.
    Laurent-Crawford AG; Krust B; Rivière Y; Desgranges C; Muller S; Kieny MP; Dauguet C; Hovanessian AG
    AIDS Res Hum Retroviruses; 1993 Aug; 9(8):761-73. PubMed ID: 8105835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane-expressed HIV envelope glycoprotein heterodimer is a powerful inducer of cell death in uninfected CD4+ target cells.
    Laurent-Crawford AG; Coccia E; Krust B; Hovanessian AG
    Res Virol; 1995; 146(1):5-17. PubMed ID: 7754236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate.
    Verrier FC; Charneau P; Altmeyer R; Laurent S; Borman AM; Girard M
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9326-31. PubMed ID: 9256481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function.
    Chiou SH; Freed EO; Panganiban AT; Kenealy WR
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1611-8. PubMed ID: 1457207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aurothiolates inhibit HIV-1 infectivity by gold(I) ligand exchange with a component of the virion surface.
    Okada T; Patterson BK; Ye SQ; Gurney ME
    Virology; 1993 Feb; 192(2):631-42. PubMed ID: 8421903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Celada F; Düzgüneş N
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment.
    Marcon L; Sodroski J
    J Virol; 1994 Mar; 68(3):1977-82. PubMed ID: 8107258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transmembrane glycoprotein of human immunodeficiency virus type 1 induces syncytium formation in the absence of the receptor binding glycoprotein.
    Perez LG; O'Donnell MA; Stephens EB
    J Virol; 1992 Jul; 66(7):4134-43. PubMed ID: 1602536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion.
    Dash B; McIntosh A; Barrett W; Daniels R
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1389-97. PubMed ID: 8207403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV.
    Koga Y; Sasaki M; Yoshida H; Wigzell H; Kimura G; Nomoto K
    J Immunol; 1990 Jan; 144(1):94-102. PubMed ID: 2404066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike.
    Eggink D; de Taeye SW; Bontjer I; Klasse PJ; Langedijk JPM; Berkhout B; Sanders RW
    J Virol; 2016 Dec; 90(23):10587-10599. PubMed ID: 27654295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered CD4 interactions of HIV type 1 LAI variants selected for the capacity to induce membrane fusion in the presence of a monoclonal antibody to domain 2 of CD4.
    Klasse PJ; Sattentau QJ
    AIDS Res Hum Retroviruses; 1996 Jul; 12(11):1015-21. PubMed ID: 8827217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syncytium formation in cultured human lymphoid tissue: fusion of implanted HIV glycoprotein 120/41-expressing cells with native CD4+ cells.
    Margolis LB; Glushakova S; Baibakov B; Zimmerberg J
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):697-704. PubMed ID: 7576929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression plasmids are only useful for the investigation of co-receptor tropism and fusion capacity of short HIV-1 envelope domains.
    Grund S; Klein A; Adams O
    J Virol Methods; 2010 Jun; 166(1-2):106-9. PubMed ID: 20304009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
    Gallo SA; Puri A; Blumenthal R
    Biochemistry; 2001 Oct; 40(41):12231-6. PubMed ID: 11591141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.
    Watkins BA; Crowley R; Davis AE; Louie AT; Reitz MS
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2513-22. PubMed ID: 9349472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.